Dr. John Leonard, longtime CEO at Intellia Therapeutics, discusses the foundational elements of building a biotech hub, the influence of the AIDS epidemic on his career, the importance of experience and knowledge in scientific research, and Intellia's long-term DNA editing strategy. He also provides updates on the company's clinical pipeline and future plans.